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Abstract The cause of inﬂuenza to the brain was inves-
tigated using the A/NWS/33 inﬂuenza virus infected
BALB/c mouse model. NOS-2 mRNA levels in the infec-
ted mouse brain was greater than in control mice in all
brain regions examined, particularly in the olfactory bulb
and hippocampus by 1 day p.i. On the contrary, no dif-
ferences in NOS-1 or NOS-3 mRNA levels were found
between infected and control mice. There was also a
marked increase in the levels of metabolites of nitric
oxide in the olfactory bulb and hippocampus. Immuno-
histochemistry showed positive staining for anti-NOS-2
primarily in the hippocampus of infected mice. Further,
anti-NOS-2 and GFAP staining was mostly found around
capillary blood vessels of the hippocampus starting early in
the course of the disease. These results indicate that the
NWS enhances the activation of astrocytes and NOS-2
expression which in turn enhances NO production and the
expansion of capillary blood vessels.
Keywords Inﬂuenza A/NWS/33 virus   BALB/c mouse  
NO   NOS-2   Astrocyte   Olfactory bulb   Hippocampus  
Brain capillary blood vessels
Introduction
Inﬂuenza associated encephalopathy (IE) is one of the most
severe neurological diseases amongst children, mostly
under the age of 5. It is marked by rapid progression and
the mortality rate is estimated to range from 27 to 44% [1].
Recently, we reported that production of the biological free
radical gas, nitric oxide (NO), in the serum and cerebro-
spinal ﬂuid (CSF) of patients with IE was increased in the
initial stages and correlated with disease severity [2, 3].
Yokota et al. hypothesized that the inﬂuenza virus
activates the limbic system followed by glial cell activation
which in turn produces NO and inﬂammatory cytokines
which ﬂood the brain and cause a cytokine storm [4].
Recent in vitro studies by Imanishi et al. showed that a
mouse lung-adapted strain of inﬂuenza virus could induce
inducible NO synthase (NOS-2) mRNA expression and
NOS-2-mediated NO production in murine macrophage
cell [5]. Moreover, Ino et al. studied ﬁve autopsies cases of
IE patients. They reported that four out of the ﬁve patients
showed degenerated astrocytic spines in the cortex, by glial
ﬁbrillary acidic protein (GFAP) staining. They suspected
that the IE was largely due to these altered glial cells (Ino
et al. unpublished).
Taken together, it is likely that IE is related to both the
inﬂuence of NO and glial cells changes. Nevertheless, there
have been no reports on a relationship between NOS-2 and
glial cells within the brain after infection with the inﬂuenza
virus. Thus, the aim of these studies is to better understand
the clinical state of IE by focusing on NO and astrocytes in
the central nervous system (CNS) after inﬂuenza virus
infection. By using the A/NWS/33 inﬂuenza virus infected
BALB/c model mouse, we were able to demonstrate that
inﬂuenza virus infection leads to an up regulation of NOS-
2 and astrocytes, mostly around capillary blood vessels of
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stage of the disease.
Although IE has been reported for more than a decade, a
therapy for IE has not yet been deﬁned. We expect that our
results will provide evidence which will aid in the devel-
opment of a novel IE therapy.
Experimental procedures
Virus
Inﬂuenza A/NWS virus, which is a mouse brain adapted
type of human inﬂuenza A/NWS/33 virus was used. (A
kind gift from Dr. K. Hayashi, Toyama University, Japan.)
Experimental animals
In total, 82 male BALB/c mice (5-week-old) were pur-
chased from Japan Charles River Co. and given free access
to food and water (Oriental Yeast, Co., Tokyo) and accli-
matized for at least a week before the experiment.
Anesthetics
Each mouse was anesthetized by inhalation of ether before
being inoculated intranasally with 50 ll NWS, 5.0 9 10
7
plaque-forming units (PFU)/ml (5.0 9 10
5 PFU/mouse).
For negative control mice, the same amounts of 0.1 M
phosphate-buffered saline (PBS) were intranasally inocu-
lated. The mice were examined at 1, 3 and 6 days
postinfection (p.i.).
Body weight
Body weight changes were monitored daily.
Euthanasia
All mice were decapitated whilst under ether inhalational
anesthesia. Each brain was divided into eight regions
(frontal cortex, occipital cortex, cerebellum, medullar
oblongata, hippocampus, corpus striatum, thalamus/hypo-
thalamus and olfactory bulb). Then each section was
immediately frozen with liquid nitrogen.
NO2
- and NO3
- measurements by HPLC-UV method
Both NO2 and NO3 (NOx) levels in each brain region were
measured by HPLC-UV system (ENO-10, EICOM) which
was reported by us [3]. Brieﬂy, thawed brain regions were
deproteinized with a ten times volume of methanol and
then centrifuged (12,000 r.p.m. for 20 min at 4C) to avoid
an occlusion in the polystyrene polymer column used in
this system, by protein or other macromolecules. Detection
was measured at 540 nm (absorption) and the concentra-
tions were calculated from the area under the curve (AUC)
of NO2 and NO3 (Power Chrome, EICOM, Kyoto) by
Griess reaction.
RNA extraction
RNA was extracted from each part of the brain by using a
QIA amp RNA extraction kit (QIAGEN K.K., Tokyo),
according to the protocol suggested by the manufacturer.
cDNA synthesis
cDNA was synthesized from puriﬁed RNA by using the
Transcriptor First Strand cDNA Synthesis Kit (Roche,
Switzerland). Random hexamer primer was used and the
protocol was as follows; after annealing for 10 min at
25C, and incubating 30 min at 55C, the reaction was
heated to 85C for 5 min and chilled on ice.
Real time reverse transcriptase-polymerase chain
reaction (RT-PCR)
Messenger RNA levels of NOS-1, NOS-2 and NOS-3 were
quantiﬁed by using a Light Cycler Fast Start DNA Master
HybProbe (Roche). This was done according to the fol-
lowing protocol; Pre-incubation was 95C for 30 s. This
was followed by 40 cycles of denaturation at 95C for 10 s,
annealing at 62C for 15 s, ampliﬁcation at 72C for 8 s for
45 cycles. Cycles were followed by 30 s 40C cooling
program. The primers and probes were designed by the
Light Cycler primer and probe set (Roche Diagnostics
Applied Science, Tokyo). NOS-2, NOS-3 and NOS-1 pri-
mer sequences were designed on GenBank database
NM_0100927, NM_008713, and NM_008712 respectively.
All data were normalized by dividing with the corre-
sponding GAPDH mRNA from the same sample.
Immunohistochemistry
Anesthetized animals were perfused intracardially with
20 ml of 0.1 M PBS, followed by 30 ml of 4% parafor-
maldehyde in 0.1 M phosphate buffer. The brains were
removed, postﬁxed overnight and cryoprotected in 30%
sucrose, processed through graded alcohols and embedded
in parafﬁn. Then, they were cut as 6 lm thick coronal
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123sections. They were incubated with 0.3% H2O2 for 20 min.
The sections were then rinsed with tris-buffered saline, pH
7.6 (TBS). To identify reactive astrocytes, we stained with
Anti-GFAP (rabbit polyclonal, DAKO, Denmark). Sections
were incubated over night at a 1:2,000 dilution. The NOS-2
stains were incubated for 4 h at a 1:1,500 dilution (Anti-
iNOS/NOSII, rabbit polyclonal IgG;Upstate Biotechnol-
ogy, Lake Placid, NY). After the ﬁrst staining, each section
was incubated with the secondary antibody for 30 min
(Nichirei Histoﬁne Simple Stain, anti-rabbit IgG) at room
temperature after TBS rinsing. Labeling was visualized by
incubating with a solution containing 2%, 3,30-diam-
inobenzidine, 0.1 M imidazole and 30% H2O2.
All sections were counterstained with Mayer’s hema-
toxylin (SIGMA, MI).
Statistical analysis
Fisher’s exact test was used when comparing body weights.
All results obtained from the real time RT-PCR were
subjected to one- or two-way analysis of variance
(ANOVA) and differences among the means were analyzed
by two-way ANOVA followed by a Newman–Keuls range
test at the 0.05 signiﬁcance level. Results are expressed as
mean ± standard error.
Results
Body weight
Figure 1 shows the change in body weight of the non-
infected (PBS) and infected (Flu) mice over day. The mice
infected with virus showed a decrease in weight and rufﬂed
hair from 3 days p.i. and by 6 days p.i. and there was a
signiﬁcant decrease in the body weight of the infected mice
as compared to the non-infected mice (P\0.05). Promi-
nent neurological signs in the infected mice did not appear
during the experimental period and none of the mice died
during the experiment, although spontaneous locomotor
activity was reduced in the infected mice.
Viral titers
At one day p.i., 120 PFU/50 mg virus was detected in the
infected mouse brain and 136 9 10
4 PFU/100 mg virus
was detected in the infected mouse lung.
Real-time RT-PCR for NOS-2, NOS-3 and NOS-1
Figure 2 shows the NOS-2/GAPDH and NOS-3/GAPDH
ratios as measured in the olfactory bulb and hippocampus
of infected mouse brains as compared to the non-infected
mice on days 1, 3 and 6 p.i. Due to the scattered results
obtained in both the infected and non-infected mice, data
on the NOS-1/GAPDH ratio is not reported. The increases
in the NOS-2/GAPDH ratio as seen in the olfactory bul-
b(OB) and hippocampus(HIP) at day 1 and 3 p.i., were
obvious as shown in Fig. 2a and b. However, no changes
were seen in the levels of NOS-3/GAPDH in the same
regions (Fig. 2a’, b’).
Changes in brain NO levels between non-infected
and infected mice
Figure 3 shows that NO levels in the eight brain regions
examined, either with or without NWS virus infection,
changes in a day-by-day manner after virus infection. The
levels of NO2 and NO3 were measured separately, as
shown in the Materials and methods. In the isolated brain
regions, NO3 levels were more than 40-fold higher than
NO2 levels, and the ﬁnal data are shown as the total value
(NO) of NO2 plus NO3. At day 1 p.i., the NO levels
detected in olfactory bulb (OB), hippocampus (HIP) and
frontal cortex (FC) of the infected mice (Flu) were sig-
niﬁcantly increased as compared to the levels in the same
brain regions of the non-infected (PBS) mice (P\0.05).
Further, at day 6 p.i., the increased levels of NO in the
olfactory bulb (OB) and the frontal cortex (FC) returned to
the levels seen in non-infected mice. However, the levels of
NO in the hippocampus (HIP) were signiﬁcantly increased
(P\0.05) at all the time points examined.
Immunohistochemistry
Figure 4 shows the results of anti-NOS-2 staining and
GFAP staining in the hippocampus of non-infected (PBS)
and infected mice (Flu) at 1 (Fig. 4a) and 6 (Fig. 4b) days
p.i. in the same magniﬁcation each. The brown-yellow
Fig. 1 Changes in body weight of A/NWS/33 inﬂuenza virus
infected BALB/c model mice after virus infection. Each result shows
the mean ± SE value of eight experiments. ( ) non-infected (PBS
treatment) mice group, ( ) infected (Flu) mice group
Neurochem Res (2008) 33:1017–1023 1019
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2. We found positive staining in the hippocampus, espe-
cially in the area surrounding capillary blood vessels of the
infected mice at 1 day p.i. (Fig. 4a, Day 1, Infected). By
6 days p.i., positive staining had spread to the striatum,
hippocampus and cortex of the infected mice and positive
staining were seen in the areas surrounding capillary ves-
sels (Fig. 4b, Day 6, Infected). Add that infected mice
showed an increase in GFAP staining on days 1 much more
so than that seen in non-infected mice. Positive staining
was most notable around hippocampal blood vessels in
infected mice. Additionally, most of the blood vessels in
Fig. 2 NOS-2/GAPDH and
NOS-3/GAPDH ratios in the
olfactory bulb and hippocampus
of non-infected and infected
mice on days 1, 3 and 6 p.i. The
open column shows the mean
and S.E. value obtained from
nine non-infected mice and the
closed column shows the mean
and S.E. value obtained from
eight infected mice. *Signiﬁcant
difference between non-infected
mice and infected mice.
*P\0.05. (a and a’): olfactory
bulb, (b and b’): hippocampus
Fig. 3 Day to day changes in NO levels in the eight brain regions
either with or without NWS virus infection. The open column shows
the mean and S.E. value obtained from eight non-infected mice and
the closed column shows the mean and S.E. value obtained from
seven infected mice. *Signiﬁcant difference between non-infected
mice and infected mice. *P\0.05. OB: olfactory bulb, HIP:
hippocampus, St: striatum, Hypo/Thal: hypothalamus and thalamus,
MO: medulla oblongata, CE: cerebellum, FC: frontal cortex, and OC:
occipital cortex
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123hippocampi of infected mice were markedly expanded as
compared to those seen in the non-infected mice.
Discussion
Since our aim was to see the effect to the brain after
inﬂuenza infection, this experiment was undertaken by
using the A/NWS/33 virus because it is proven by Li et al
that the NWS/33 strain can replicate in the brain of adult
mice after intracerebral injection, add that the virus usually
fails to spread beyond the respiratory epithelium after
internasal instillation [6].
During the experiment, we observed that the NWS virus
infected mice lose signiﬁcantly more body weight at 6 days
p.i. (Fig. 1) in agreement with previous studies [5, 7]. Since
bodyweight changes are an indicator of the overall condi-
tion of the mice, this bear out that the mice was infected to
the virus. More over, we have checked that RT-PCR for A/
NWS/33 virus were positive in all brain regions expect
medullar oblongata on day 1 p.i. (data not shown).
The reason why we determined the amounts of inﬂuenza
virus in this experiment is as followed. During the past
experiment, we had experienced that the mice die within
3 days p.i. when inoculating any more than the virus we
used this time and when we use fewer viruses, there were
hardly any difference in the non-infected and infected
behavioral change.
Our results show that an enhancement NO biosynthesis
was induced in the NWS virus infected mouse brain. Over-
production of NO was substantiated by determining an
increase in the expression of NOS-2 mRNA as shown in
Fig. 2, and increased immuno-histochemical staining for
anti-NOS-2 as shown in Fig. 4. At 1 day p.i., the amount of
NOS-2 mRNA within the infected mouse brain was greater
than that seen in control mice in all brain regions studied.
Above all, the olfactory bulb showed the greatest increase.
On the basis of these results, we compared NOS-2 mRNA
expression in the olfactory bulb on days 1, 3, and 6 p.i.,
respectively. This showed that the NOS-2 mRNA ratio was
greater in the infected mouse brain at all experimental
times studied (Fig. 2). On the contrary, there was no
difference in NOS-3 or NOS-1 mRNA levels between
infected and control mice (data not shown). These results
are important since these three isoforms of NOS, NOS-2
the inducible form of NOS, is capable of producing a
continuous ﬂux of NO and a large amount of NO generated
by NOS-2 over a sustained period is implicated in the
pathogenesis of various disorders and with the response to
infectious organisms [8].
Fig. 4 Anti-NOS-2
immunohistochemistry and
GFAP immunohistochemistry in
the hippocampus at 1 (Fig. 4a)
and 6 (Fig. 4b) days p.i
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tive staining for anti-NOS-2 was mostly detected in the
hippocampus of infected mouse brains, whereas hardly any
staining was seen in control brains (Fig. 4). Furthermore,
positive staining had spread to the hippocampus and stri-
atum by 6 days p.i., which correlated with the transition of
NO levels.
NOS-2 has been shown to play a role in the defense
against bacteria, parasites and viruses. However, it seems
that NO induced by the inﬂuenza virus has a dual role.
Rimmelzwaan et al. reported an inhibitory effect of NO on
virus growth [9], whereas Akaike et al. reported that NO
played a pathological role in the inﬂuenza virus-induced
pneumonia in mice [10]. The fact that the inﬂuenza virus
can induce NO has been reported previously [2, 3]. Yao
et al. reported that the mRNA’s of both NOS-2 and NOS
increased in the brain after the intranasal infection with
inﬂuenza A virus of newborn mice [11]. Further, Imanishi
et al. pointed out that a mouse lung-adapted strain of
inﬂuenza virus could induce NOS-2 mRNA expression and
NOS-2-mediated NO production in murine macrophage
cells [5]. Our study has demonstrated that the NWS virus
can induce NOS-2 expression in the infected mouse brain,
especially in the olfactory bulb and hippocampus. These
results may relate to the fact that intranasally administered
NWS virus can invade the brain through the olfactory
pathway as has been reported previously [12–16].
Recently, Yossi et al. reported that astrocytes are capable
of rapid and massive NOS-2-dependent NO production in
brains of normal mice in situ [17]. According to the report
by Ino et al. on the brain autopsy of patients who had died
of IE, four out of ﬁve IE patients showed degenerated
astrocytic spines in the cortex by GFAP staining. They
suspected that the IE was largely due to altered glial cells
(Ino et al. unpublished). Takahashi et al. also made a
statement on the autopsied case of a 2-year-old girl with
encephalopathy associated with inﬂuenza A virus infection
and according to their report; reactive astrocytes were seen
in the vicinity of blood vessel in the brain but astrocytosis
was not seen anywhere, including the areas where virus
antigen-positive neurons were abundant [18]. Additionally,
Yokota et al. hypothesized that the inﬂuenza virus activates
the limbic system followed by the activation of glial cells
which produce NO and other inﬂammatory cytokines
which together ﬂood the brain and cause a cytokine storm
[4]. Astrocytes are the major glial cell in the CNS and have
important physiological properties in terms of CNS
homeostasis. Astrocytes also inﬂuence the formation and
maintenance of the blood–brain barrier (BBB). The
importance of astrocytes is demonstrated by a study from
Bush et al. According to their report, an astrocyte ablation
led to failure of BBB repair and vasogenic edema [19].
There have been several reports related to glial cells and
NO [17, 20, 21]. However, there has not been a report
considering the relationship between inﬂuenza virus
infection, NOS-2 and astrocytes together. By determining
an increase in GFAP staining as shown in Fig. 4, our
results show that astrocytes are activated in the infected
mouse brain and especially in hippocampus. Interestingly,
we noticed that both the increased NOS-2 and GFAP
staining were mostly found around capillary blood vessels
of the hippocampus starting at an early stage. Our results
suggest that since NOS-2 and astrocytes became activated
around capillary blood vessels after viral infection, this
may lead to brain capillary blood vessels break down.
However, we were unable to determine whether the NOS-2
measured is derived from vascular endothelial cells or
macrophages which will be an issue for future experiments.
Although IE has been mostly reported in Asian coun-
tries, inﬂuenza infection occurs in epidemics in both the
northern and southern hemispheres and is a pandemic
disease throughout the year. Recently, inﬂuenza virus
which is resistant to anti-inﬂuenza drugs has been shown to
emerge and there is real concern in regards to a new type of
inﬂuenza pandemic [22]. However, no standardized ther-
apy for the treatment of IE has yet been deﬁned. In this
paper, we suggest that the inﬂuenza virus causes the acti-
vation of astrocytes and NOS-2 in the brain. Thus it is
likely that our results will add supportive evidence for the
development of a novel IE therapy.
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